雜志介紹

Current Drug Therapy雜志介紹

《Current Drug Therapy》是一本以English為主的未開放獲取國際優秀期刊，中文名稱目前的藥物治療，本刊主要出版、報道領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為0.3，最新CiteScore 指數為1.3。

英文介紹

Current Drug Therapy雜志英文介紹

Current Drug Therapy covers a wide range of research, including cancer, nanoparticles, liposomes, chemotherapy, bioavailability, nanotechnology, radiotherapy, Alzheimer's disease, diabetes, psoriasis, vaccines, drug resistance, oxidative stress, bevacizumab, quality from design, drug delivery, inflammation, nano medicine and other hot topics. These themes reflect the latest trends and cutting-edge research in the field of drug therapy.

This journal has a certain influence in the academic community, with an impact factor (2023) of 0.302. Although relatively low, it still plays an important role in the field of drug therapy. The papers published in journals undergo rigorous peer review to ensure their quality and academic value. In addition, the journal also emphasizes interaction with readers and authors, providing practical information such as submission experience sharing and author knowledge, which facilitates researchers to better understand and participate in the journal's submission and publication process.